Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Azithromycin for Prevention of Disease Progression in Patients With Mild or Moderate COVID-19

NCT04332107 is registered in ClinicalTrials.gov with Thomas M. Lietman as lead sponsor.

NCT NCT04332107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04332107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Azithromycin for Prevention of Disease Progression in Patients With Mild or Moderate COVID-19
Lead sponsor
Thomas M. Lietman
Phase
Phase 3
Overall status
Terminated
Start date
May 22, 2020
Completion date
March 30, 2021
Enrollment
263 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2